文献速递血液透析通路

经皮与外科创建动静脉透析瘘管的比较

Comparison of surgical versus percutaneously created arteriovenous hemodialysis fistulas.
PubMed 文献 · J Vasc Surg · 2021-02-04

单中心回顾性研究比较107例Ellipsys经皮动静脉瘘(p-AVF)与同期107例外科动静脉瘘(s-AVF)。p-AVF 6周成熟率更高(65% vs 50%;s-AVF外科翻修率(36% vs 17%;

要点

  • s-AVF 12个月一期通畅率更高,但24个月时两组无差异。
  • s-AVF外科翻修及伤口愈合/感染问题更频繁。

核心结论

  • Ellipsys系统经皮创建的动静脉瘘成熟率更高,通畅性与经验丰富的外科瘘相当。
  • p-AVF伤口愈合问题、感染及外科翻修风险更低。
  • 需更大规模前瞻性随机多中心研究证实。

研究设计与样本

  • 单中心回顾性比较研究。
  • 纳入2017年5月至2018年5月首批107例Ellipsys经皮动静脉瘘患者,及同期等量连续外科动静脉瘘患者。

主要发现

  • 12个月(90% vs 91%)和24个月(88% vs 91%)二期通畅率无显著差异。

临床怎么用

  • 经皮动静脉瘘可作为需快速成熟患者的可选方案。
  • 外科动静脉瘘在12个月一期通畅率上可能更优,但需权衡翻修及感染风险。
  • 选择术式时应结合患者透析状态、感染风险及预期寿命个体化决策。

局限性

  • 单中心回顾性设计,存在选择偏倚可能。
  • 样本量有限(每组107例),随访至2年。
  • 结果需前瞻性随机多中心研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of the present study was to compare the results between percutaneous arteriovenous fistulas (p-AVFs) created with the Ellipsys device (Ellipsys Vascular Access System; Avenu Medical, San Juan Capistrano, Calif) and surgical arteriovenous fistulas (s-AVFs). METHODS: A single-center retrospective comparative study of the first 107 patients who had undergone p-AVF creation with the Ellipsys system from May 2017 to May 2018 with an equal number of consecutive patients who had undergone s-AVF creation in our center during the same period. The primary endpoints included the maturation and patency rates. The secondary endpoints were reintervention, risk of infection, and the incidence of steal syndrome and aneurysm formation. RESULTS: The demographic, hypertension, and diabetes data were similar for both groups. The only difference between the two groups was that more p-AVF patients had already been receiving hemodialysis (61% vs 47%; P < .05). The p-AVFs showed superior maturation rates at 6 weeks (65% vs 50%; P = .01). The primary patency rates were greater for the s-AVFs at 12 months (86% vs 61%; P < .01). However, primary patency was comparable between the two groups at 24 months (52% vs 55%; P = .48). No significant difference was found in the secondary patency rates at 12 (90% vs 91%) and 24 (88% vs 91%) months. At the 2-year follow-up point, the rate of percutaneous reintervention was similar; however, the s-AVFs had required more frequent surgical revision (36% vs 17%; P = .01). Issues with wound healing and infection were also more frequent with s-AVFs (9% vs 0.9%; P < .01). CONCLUSIONS: Fistulas created percutaneously with the Ellipsys system showed superior maturation rates and similar patency with s-AVFs created in an experienced high-volume vascular surgery practice. p-AVFs had a lower risk of wound healing issues, infection, and surgical revision. Larger, prospective, randomized multicenter studies are needed to confirm these findings.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Harika G, Mallios A, Allouache M, et al. Comparison of surgical versus percutaneously created arteriovenous hemodialysis fistulas. J Vasc Surg. 2021. PMID: 33548442. doi:10.1016/j.jvs.2020.12.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。